Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.
Xia W, Qian Y, Lin Y, Quan R, Yang Y, Yang Z, Tian H, Li S, Shen J, Ji Y, Gu Q, Han H, Xiong C, He J.
Xia W, et al. Among authors: qian y.
Respirology. 2024 Mar 17. doi: 10.1111/resp.14700. Online ahead of print.
Respirology. 2024.
PMID: 38494833
BACKGROUND AND OBJECTIVE: Off-label pulmonary arterial hypertension (PAH)-targeted drugs are commonly prescribed for non-operated chronic thromboembolic pulmonary hypertension (CTEPH), but their effect on the long-term prognosis of CTEPH remains unknown. This study investi …
BACKGROUND AND OBJECTIVE: Off-label pulmonary arterial hypertension (PAH)-targeted drugs are commonly prescribed for non-operated chronic th …